Skip to main content

How Prescription Drug Importation Can Lower Drug Prices

How Prescription Drug Importation Can Lower Drug Prices

The cost of prescription drugs in the U.S. is the highest in the developed world and is rising quickly. Americans often pay more for prescription drugs than individuals in comparable countries. According to a 2021 RAND Corporation study, U.S. prescription drug prices were 2.56 times higher, on average, than those in the 32 comparison countries. It’s no surprise many Americans struggle to afford the prescription drugs they need.

Addressing the lack of affordable prescription drugs is a top public health priority in the U.S. Prescription drug importation is one option some policymakers are pursuing to lower drug prices for Americans. While prescription drug importation has bipartisan public support, it remains a controversial issue with benefits and risks that must be examined.

This article explores the potential impacts of prescription drug importation on U.S. drug prices.

What is prescription drug importation?

Prescription drug importation is the practice of purchasing prescription drugs from another country and importing them to the U.S. The goal is to save money on prescription drug costs, as prices for many drugs are lower in other countries. Currently, it’s illegal to import prescription drugs into the U.S. from other countries except under limited circumstances. However, there have been proposals to legalize prescription drug importation to lower drug prices, increasing Americans’ access to affordable medications.

What is the current state of prescription drug importation?

Currently, U.S. law only permits certain drugs from Canada to be imported and sold in the U.S. under limited circumstances.

For an imported prescription drug to be sold in the U.S., it must meet the standards established in the Food and Drug Cosmetic Act of 1938 and be approved by the Food and Drug Administration. Only FDA-approved drugs manufactured in an FDA-inspected facility, intended for U.S. consumers and imported into the U.S. by drug manufacturers are permitted.

In rare circumstances, prescription drugs approved and manufactured in the U.S. and sent abroad may be imported back into the U.S. An example is when the importation is under the direction of the secretary of the U.S. Department of Health and Human Services for emergency medical purposes and by the original drug manufacturer in situations where a drug has been damaged or recalled.

Even though federal law allows prescription drug importation from Canada, the HHS secretary must still certify to Congress that importation will provide significant savings for U.S. consumers and will not threaten the general public’s health and safety.

In 2020, the Trump administration issued a final rule and final FDA guidance for prescription drug importation. This allowed states, territories and Native American tribes — and some wholesalers and pharmacists — to implement time-limited importation programs for certain drugs currently marketed in the U.S. from Canada. Under the administration’s final rule, states must submit their importation proposals to the HHS secretary for approval.

Similar to the Trump administration’s efforts, President Joe Biden issued an executive order in July 2021 directing the FDA to work with states to import prescription drugs from Canada. This proposal has strong bipartisan public support. Some states, including Florida, Vermont, Colorado and Maine, have enacted laws establishing prescription drug importation programs. However, to date, no plans have obtained the required certification by the HHS Secretary, largely due to safety concerns. The FDA is still working to implement a statutory pathway for the importation of drugs originally intended for foreign markets.

Recently, a U.S. district court dismissed a lawsuit by pharmaceutical industry members to stop state governments from importing prescription medications from Canada. This ruling may encourage more states to consider importing medications from Canada as a strategy to lower the costs of prescription drugs for Americans.

Can individuals import prescription drugs for personal use?

Except in limited circumstances, individuals cannot import FDA-approved drugs for personal use. Permission to import prescription drugs that have not been approved by the FDA is granted on a case-by-case basis and is usually only allowed to treat serious health conditions where there is no effective treatment available in the U.S.

However, some Americans purchase lower-cost prescription drugs from other countries, even though this is illegal in most situations. For example, according to a 2016 Kaiser Family Foundation poll, approximately 8% of respondents said they or someone in their household had imported a drug at some point. This equates to nearly 19 million Americans illegally importing medications. This willingness to import medications illegally is a strong indication that many Americans are unable to afford the costs of their prescription drugs.

Will prescription drug importation lower U.S. drug prices?

The goal of prescription drug importation is to lower drug prices for Americans. If successful, it could improve the health and well-being of the American public. However, despite its admirable goal, prescription drug importation remains controversial, with many doubting its merits.

The argument in favor of prescription drug importation is that it offers a way to provide safe, low-cost drugs to many Americans, which could improve access to needed and life-saving medications. Wholesale drug importation may also increase competitiveness among U.S. drug manufacturers, resulting in cost savings and lower prices. Canada’s single-payer health care system allows the government to negotiate directly with drug companies to reduce prices. So, allowing these lower-cost drugs to be marketed and sold in the U.S. may force U.S. drug companies to reduce their prices to remain competitive.

However, many are skeptical that prescription drug importation will lower drug costs in the U.S. Currently, many high-cost drugs, e.g., biologic products (insulin) and narcotics, cannot be imported. If importation of prescription drugs is legalized, potential costs savings could be limited if these exclusions continue.

Additionally, since any drugs imported to the U.S. would first go through Canadian negotiations with manufacturers, there’s no guarantee that prices would be lower. Before Canadian drugs could be sold in the U.S., they would likely need to be inspected, tested, repackaged, relabeled and tracked. This would likely require significant government oversight, potentially leading to increased costs.

Importing prescription drugs from Canada could also increase demand for those drugs in Canada, driving up prices. Every year, drug manufacturers typically allocate the number of drugs to be sold in each country individually. This is done by assessing past drug sales and estimating anticipated increases for the following year. Manufacturers are unlikely to increase Canada’s allotment of prescription drugs so those drugs can be redistributed to the U.S., especially since the U.S. is a larger and more lucrative market than Canada.

There are also concerns over whether importing drugs from Canada could meet U.S. demand. Further, it’s difficult to ensure the effectiveness, quality and safety of imported drugs.

Overall, lowering prescription drug costs is a priority for the American public. While there are questions about whether prescription drug importation will lower U.S. drug prices, it’s an option policymakers and states continue to explore.

Wrap-up: What employers can do

Reducing the cost of prescription drugs in the U.S. is critical. Prescription drug importation offers one way to potentially increase access and affordability to necessary and life-saving drugs for many Americans. This is a developing issue that employers should continue to monitor closely.

Contact HANYS Benefit Services today to learn more about employee benefits and how prescription drugs could influence your offerings. Our dedicated team of experts is ready to assist.


This Benefits Insights is not intended to be exhaustive nor should any discussion or opinions be construed as professional advice. © 2023 Zywave, Inc. All rights reserved.

Popular posts from this blog

What are Alternative Investments? 4-Part Introduction

The market has seen a lot of uncertainty in recent years. Because of this, many organizations are looking for new ways to diversify their investment portfolios. Our best-kept “not-so-secret” secret: alternative investments. In this blog, we'll explore alternative investments with a focus on how they can potentially shield your portfolios from downside market volatility. In addition, we'll break down its benefits and risks and whether it could be a good fit for you. Part 1: What are alternative investments? Alternative investments may help diversify your investment portfolios through non-traditional investment strategies. Non-traditional investment options have varying liquidity ranges depending on the strategy and fund structure. Alternative investments are sometimes referred to as alternative assets. According to the Harvard Business School , the seven types of alternative investments are: private equity; private debt; hedge funds; real estate; commodities; collectibles; and s

Employee benefits strategies: 5 budget-friendly ideas

Retirement and employee benefits help create a solid foundation for recruitment and retention. They’re also pivotal in enhancing job satisfaction, boosting productivity, encouraging employee well-being and increasing workplace morale. With the work landscape evolving rapidly, organizations are revisiting their offerings to develop stronger employee benefits strategies.  The first area most small- and mid-size employers investigate is quick, short-term ways to foster company culture. In this blog, we’ll cover budget-friendly ideas to improve your employee benefits initiatives. Think of them as smaller action items that can help you gain a competitive edge. Then, we’ll take a closer look at how customizing your benefits plan can support your new efforts.  1. Promote a healthy work culture  Investing in employee benefit plans is not just about fulfilling a checklist. It's about creating an environment where employees feel supported in both their professional and personal lives. Benefi

Section 125 – Cafeteria Plans Overview

A Section 125 plan, or cafeteria plan , allows employees to pay for certain benefits on a pre-tax basis. Employers use these plans to provide their employees with a choice between cash and certain qualified benefits without adverse tax consequences. Paying for benefits on a pre-tax basis reduces the employee’s taxable income and, therefore, reduces both the employee’s and the employer’s tax liability. To receive these tax advantages, a cafeteria plan must comply with the rules of Section 125 of the Internal Revenue Code and related IRS regulations. Under these rules, a Section 125 plan must have a written plan document and can only offer certain qualified benefits on a tax-favored basis. Once an employee makes a Section 125 plan election, they may not change that election until the next plan year, unless the employee experiences a permitted election change event. Also, for highly compensated employees to receive the tax advantages associated with a Section 125 plan, the plan must pass